Key points

  • L1 Capital Pty Ltd bought $3.03 million of Anteris Technologies Global Corp. stock. The purchases covered 397,226 shares and were reported across two separate filings.
  • The transactions carry a date of October 1st, 2026. Reported prices ran from $7.60 to $7.72 per share.
  • The buyer is an institution, not an officer or a director. L1 Capital Pty Ltd is filed in the role category of Other, the bucket that typically covers holders reporting by virtue of size rather than an operating title.
  • The last price of $7.71 sits inside the reported buying range. That leaves no visible gap between what the firm paid and where the stock trades now.

L1 Capital Pty Ltd disclosed the purchase of 397,226 shares of Anteris Technologies Global Corp., a transaction worth $3.03 million at the prices reported. The buying is dated October 1st, 2026 and reached the tape through two filings rather than one.

Anteris Technologies Global Corp. trades under the ticker AVR and sits in the orthopedic, prosthetic and surgical appliances and supplies sector. The company carries a market capitalization of $751,404,800.

What the filing shows

The disclosure records open market purchases, not grants, not option exercises, and not a sale of any portion of the position. The share count is precise at 397,226, and the dollar figure attached to it is $3.03 million.

Two filings covering a single transaction date is a normal pattern for an institution that buys through more than one account or fund vehicle. It does not imply two separate decisions, and the combined figure is the one that matters for size.

Who the buyer is

L1 Capital Pty Ltd is an entity, so the usual insider framing does not apply cleanly here. The firm is not an executive with a desk inside the company and is not a director sitting on the board. It is filed under the role of Other, which is where reporting holders land when their obligation comes from the size of their stake rather than from a job title.

That distinction changes how the purchase should be read. An officer buying stock is signing a document about a business that officer runs day to day. An institution buying stock is an outside allocator adding to a position, and the filing says nothing about the reasoning behind it. What it does say is that the firm put $3.03 million to work in a single reported session.

Where the stock sits

The reported purchase range of $7.60 to $7.72 is narrow, which is consistent with buying concentrated into one date rather than scaled over weeks. The last price of $7.71 falls within that band.

For readers who track whether insiders and large holders bought well, there is no spread to measure yet. The stock has not moved away from the reported range in either direction, so the position is effectively flat against the prices disclosed.

What that leaves

Set the $3.03 million against the company's market capitalization of $751,404,800 and this is a position-level trade rather than a move that redraws the register. It is still a cash purchase on the open market, which is the one category of insider and large holder activity that is not explained away by compensation schedules or automatic plans.

The things the filing does not contain are worth naming. There is no statement of intent, no commentary on the business, and no indication of whether the firm intends to add further. Anteris Technologies Global Corp. operates in the surgical appliances and supplies sector, where product and regulatory timelines drive much of the news flow, and none of that appears in a purchase disclosure.

What a reader can take from this is narrow and factual. An institutional holder bought 397,226 shares on October 1st, 2026, paid between $7.60 and $7.72, reported it in two filings, and the stock last changed hands at $7.71. Anything beyond that is inference, and the document does not support it.

Sources: SEC Form 4 filings submitted via EDGAR and reviewed by InsiderBuying.com, covering transactions dated October 1st, 2026.

Informational only, not investment advice.